Don’t Delay Lung Cancer Immunotherapy Treatment Over Fear of COVID-19

Updated August 8th, 2022

Don’t Delay Lung Cancer Immunotherapy Treatment Over Fear of COVID-19

NOW
PLAYING
'Practice Changing' Lung Cancer Trial Shows Power Of The Drug Tagrisso
NOW
PLAYING
Study Shows Imfinzi, Chemotherapy Boost Survival In Metastatic Lung Cancer Patients
NOW
PLAYING
Are Some Cancers Preventable? New Study Says Yes
NOW
PLAYING
Coping with a Metastatic Lung Cancer Diagnosis
NOW
PLAYING
How Does Tabrecta Treat Advanced Lung Cancer?
NOW
PLAYING
'Game-Changing' Drug Enhertu Now Approved for Certain Types of Lung Cancer — What Does This Mean for Patients?

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... lung cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Later Stage Treatment: The Importance of Biomarker Testing

SEE MORE   

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.

Later Stage Treatment: The Importance of Biomarker Testing

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.